Literature DB >> 26470608

Bacteriology of hidradenitis suppurativa/acne inversa: A review.

Georgios Nikolakis1, Olivier Join-Lambert2, Ioannis Karagiannidis1, Hélène Guet-Revillet2, Christos C Zouboulis3, Aude Nassif4.   

Abstract

Given that follicular papules and pustules, as well as nodules and abscesses, are the clinical hallmarks of hidradenitis suppurativa (HS), an infectious, bacterial pathway has been suspected in the pathogenesis of this chronic, inflammatory condition. Elucidating the behavior and role of bacterial species in HS and their interaction with cutaneous innate immunity will provide more insight into the pathophysiology of this condition. This review of prospective investigations suggests a synergistic relationship between impaired innate immunity and microbial factors in the etiology of HS.
Copyright © 2015 American Academy of Dermatology, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Staphylococcus lugdunensis; acne inversa; actinomycetes; anaerobes; bacterial metagenomics; bacteriology; biofilm; hidradenitis suppurativa; milleri group streptococci

Mesh:

Substances:

Year:  2015        PMID: 26470608     DOI: 10.1016/j.jaad.2015.07.041

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  13 in total

Review 1.  An Update on Medical Treatment Options for Hidradenitis Suppurativa.

Authors:  I E Deckers; E P Prens
Journal:  Drugs       Date:  2016-02       Impact factor: 9.546

Review 2.  Establishing Tolerance to Commensal Skin Bacteria: Timing Is Everything.

Authors:  Tiffany C Scharschmidt
Journal:  Dermatol Clin       Date:  2017-01       Impact factor: 3.478

3.  The Follicular Skin Microbiome in Patients With Hidradenitis Suppurativa and Healthy Controls.

Authors:  Hans Christian Ring; Jonathan Thorsen; Ditte M Saunte; Berit Lilje; Lene Bay; Peter Theut Riis; Niels Larsen; Lee O'Brien Andersen; Henrik V Nielsen; Iben M Miller; Thomas Bjarnsholt; Kurt Fuursted; Gregor Borut Jemec
Journal:  JAMA Dermatol       Date:  2017-09-01       Impact factor: 10.282

Review 4.  [Pathogenesis of hidradenitis suppurativa/acne inversa].

Authors:  G Nikolakis; G Kokolakis; K Kaleta; K Wolk; R Hunger; R Sabat; C C Zouboulis
Journal:  Hautarzt       Date:  2021-07-06       Impact factor: 0.751

Review 5.  Hidradenitis suppurativa.

Authors:  Robert Sabat; Gregor B E Jemec; Łukasz Matusiak; Alexa B Kimball; Errol Prens; Kerstin Wolk
Journal:  Nat Rev Dis Primers       Date:  2020-03-12       Impact factor: 52.329

Review 6.  Are Bacteria Infectious Pathogens in Hidradenitis Suppurativa? Debate at the Symposium for Hidradenitis Suppurativa Advances Meeting, November 2017.

Authors:  Haley B Naik; Aude Nassif; Mayur S Ramesh; Gregory Schultz; Vincent Piguet; Afsaneh Alavi; Michelle A Lowes
Journal:  J Invest Dermatol       Date:  2018-11-08       Impact factor: 8.551

7.  [Psychiatric comorbidities in hidradenitis suppurativa/acne inversa].

Authors:  Paraskevi Mavrogiorgou; Georg Juckel; Andreas Reimelt; Schapoor Hessam; Lisa Scholl; Jessica Lisa Frajkur; Eggert Stockfleth; Falk G Bechara
Journal:  Hautarzt       Date:  2021-01-04       Impact factor: 0.751

8.  Water-soluble egg membrane enhances the immunoactivating properties of an Aloe vera-based extract of Nerium oleander leaves.

Authors:  Kathleen F Benson; Robert A Newman; Gitte S Jensen
Journal:  Clin Cosmet Investig Dermatol       Date:  2016-11-03

9.  Fatal New-Onset Congestive Heart Failure Related to Adalimumab Use in a Patient with Relapsing Hidradenitis Suppurativa: A Case Report.

Authors:  Claudia Mansitó López; Paola Torres Laboy; Miguel Ortiz Bou; Aida Quintero Noriega; Vielka Cintron Rivera
Journal:  Am J Case Rep       Date:  2021-02-10

10.  Irrelevance of Panton-Valentine leukocidin in hidradenitis suppurativa: results from a pilot, observational study.

Authors:  Monica Corazza; Alessandro Borghi; Vincenzo Bettoli; Roberto Pora; Ilaria Bononi; Elisa Mazzoni; Elisa Mazzola; Silva Saraceni; Martina Maritati; Carlo Contini
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2020-08-07       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.